In Vitro Evaluation of Anti-Rift Valley Fever Virus, Antioxidant and Anti-Inflammatory Activity of South African Medicinal Plant Extracts
Rift valley fever virus (RVFV) is a mosquito-borne virus endemic to sub-Saharan African countries, and the first sporadic outbreaks outside Africa were reported in the Asia-Pacific region. There are no approved therapeutic agents available for RVFV; however, finding an effective antiviral agent agai...
Main Authors: | Garland K. More, Raymond T. Makola, Gerhard Prinsloo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/2/221 |
Similar Items
-
An Overview of Rift Valley Fever Vaccine Development Strategies
by: Paul Kato Kitandwe, et al.
Published: (2022-10-01) -
Rift Valley Fever Outbreak, Mauritania, 1998: Seroepidemiologic, Virologic, Entomologic, and Zoologic Investigations
by: Pierre Nabeth, et al.
Published: (2001-12-01) -
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus
by: William C. Wilson, et al.
Published: (2016-05-01) -
Characterisation of the protective immune response to Rift Valley fever virus after natural exposure or vaccination with ChAdOx1 RVF
by: Wright, D
Published: (2022) -
Multiple Rift Valley Fever outbreaks in Uganda: Should there be global concern?
by: Ranjit Sah, et al.
Published: (2022-12-01)